Pharmala Biotech Holdings Inc. (MDXXF)
OTCMKTS · Delayed Price · Currency is USD
0.0715
+0.0028 (4.14%)
Feb 11, 2026, 9:30 AM EST
Pharmala Biotech Holdings Market Cap
Pharmala Biotech Holdings has a market cap or net worth of $7.59 million as of February 12, 2026. Its market cap has decreased by -53.11% in one year.
Market Cap
7.59M
Enterprise Value
6.93M
Revenue
540.16K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.07
Market Cap Chart
Since January 11, 2022, Pharmala Biotech Holdings's market cap has increased from 5.27M to 7.59M, an increase of 44.11%. That is a compound annual growth rate of 9.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 7.61M | -12.86% |
| Dec 31, 2025 | 8.74M | -51.35% |
| Dec 31, 2024 | 17.96M | 94.90% |
| Dec 29, 2023 | 9.21M | 500.93% |
| Dec 30, 2022 | 1.53M | -70.88% |
| Jan 11, 2022 | 5.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AccuStem Sciences | 10.19M |
| Biomind Labs | 8.84M |
| Zenith Capital | 7.99M |
| Curative Biotechnology | 7.87M |
| NKGen Biotech | 7.84M |
| BetterLife Pharma | 7.44M |
| Synlogic | 7.25M |
| LakeShore Biopharma | 6.63M |